As of 2025-05-06, the Relative Valuation of Brickell Biotech Inc (BBI) is (211.32) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.35 USD, the upside of Brickell Biotech Inc based on Relative Valuation is -9092.5%.
The range of the Relative Valuation is (190.05) - (244.92) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 36.8x | 25.8x |
| Forward P/E multiples | 23.9x - 30.8x | 27.4x |
| Fair Price | (190.05) - (244.92) | (211.32) |
| Upside | -8187.3% - -10522.1% | -9092.5% |
| Date | P/E |